Company intelligence / Profile preview

Lyme Ventures

Greenwich, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Lyme Ventures is a venture capital fund dedicated to investing in companies that address Lyme disease and other tick-borne illnesses. Launched to accelerate the development of diagnostics, therapeutics, and prevention technologies, the fund seeks to bridge the funding gap in a historically underserved area of healthcare. It focuses on supporting early-stage startups and innovative research that can be translated into clinical solutions for patients. By leveraging a network of scientific advisors and industry experts, Lyme Ventures aims to improve the standard of care and reduce the global burden of tick-borne diseases.

Therapeutic areas: Infectious Diseases
Industry: Investors

Partnerships

Global Lyme Alliance

Beyond the preview

Go deeper on Lyme Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lyme Ventures.

Explore the full profile